
IMX102 - Drug Targets, Indications, Patents - Synapse
Understand key drug designations in just a few clicks with Synapse. IMX102, Initially developed by Imunexus Therapeutics Ltd., Now, its global highest R&D status is Preclinical, Therapeutic Areas: Neoplasms,Immune System Diseases,Hemic and Lymphatic Diseases, Active Indication: Lymphoid Leukemia, Active Org.: Imunexus Therapeutics Ltd..
IMX102(IMX102) - 在研适应症:淋巴细胞白血病_专利_临床_研发
IMX102,由Imunexus Therapeutics Ltd. (Imunexus Therapeutics Ltd.)公司最早进行研发,目前全球最高研发状态为临床前,治疗领域: 肿瘤,免疫系统疾病,血液及淋巴系统疾病,在研适应症: 淋巴细胞白血病,在研机构: Imunexus Therapeutics Ltd.。
IMX102U-TL Power Integrations | Integrated Circuits (ICs) | DigiKey
IMX102U-TL – LED Driver IC 1 Output DC DC Controller Flyback Analog, PWM Dimming 28-HSOP from Power Integrations. Pricing and Availability on millions of electronic components from Digi-Key Electronics.
ABB IMX102 programmable controller - Yuanmiao Automation
ABB has a wide range of product lines, including a full range of power transformers and distribution transformers, high, medium, and low voltage switchgear products, AC and DC transmission and distribution systems, power automation systems, various measuring equipment and sensors, real-time control and optimization systems, robot software and ha...
IMX102U-TL Power Integrations | 集成电路(IC) | DigiKey
当天下单,当天发货。来自 Power Integrations 的 IMX102U-TL – LED 驱动器 IC 1 输出 DC DC 控制器 反激 模拟,PWM 调光 28-HSOP。Digi-Key Electronics 提供数以百万计电子元器件的定价和供应信息。
Imunexus Therapeutics Ltd.: 药物管线_专利_临床试验_投融营收_最 …
了解Imunexus Therapeutics Ltd.公司的药物管线,治疗领域,技术平台,以及它的,疾病领域:感染,免疫系统疾病,血液及淋巴系统疾病,内分泌与代谢疾病,肿瘤,技术平台:生物药,药物:IMX104,IMX105,IMX106,IMX103,IMX102。
IMX102U-TL中文资料下载原装现货意法半导体-114ic电子网
2023年9月2日 · 集成电路(IC) LED驱动器IMX102U-TL资料datasheet下载、封装供应价格13条,IMX102U-TL技术资料参数,POWERINT供应商报价意法半导体由114ic电子网提供
Technology | imunexus
Imunexus’ proprietary rapid-screen technology can identify new, target specific Imunexins TM and convert existing antibodies and enzymes into bispecifics at a fraction of the cost of traditional bispecific drug discovery.
Imunexus Therapeutics Ltd. - Drug pipelines, Patents ... - Patsnap
IMX102. Target-Mechanism-Active Org. Imunexus Therapeutics Ltd. Originator Org. Imunexus Therapeutics Ltd. Active Indication. Lymphoid Leukemia. Inactive Indication-Drug Highest Phase Preclinical. First Approval Ctry. / Loc.-First Approval Date-IMX-39. Target-Mechanism-
Imunexus Therapeutics Ltd. (Imunexus Therapeutics Ltd.) - 药物管 …
了解Imunexus Therapeutics Ltd. (Imunexus Therapeutics Ltd.)公司的药物管线,治疗领域,技术平台,以及它的,疾病领域:肿瘤,免疫系统疾病,血液及淋巴系统疾病,内分泌与代谢疾病,感染,神经系统疾病,技术平台:生物药,酶,药物:IMX104,IMX106,IMX-39,IMX-113,IMX105。
- 某些结果已被删除